Dynamic susceptibility contrast (DSC) perfusion MRI provide information about differences in macro-and microvasculature when executed with gradient-echo (GE; sensitive to macrovasculature) and spin-echo (SE; sensitive to microvasculature) contrast. This study investigated whether there are differences between macro-and microvascular transit time heterogeneity (MVTH and mVTH) and tissue oxygen tension (PO2 mit ) in newly-diagnosed and recurrent glioblastoma. Fifty-seven patients with glioblastoma (25 newly-diagnosed/32 recurrent) were examined with GE-and SE-DSC perfusion sequences, and a quantitative blood-oxygen-level-dependent (qBOLD) approach. Maps of MVTH, mVTH and coefficient of variation (MCOV and mCOV) were calculated from GE-and SE-DSC data, respectively, using an extended flow-diffusion equation. PO2 mit maps were calculated from qBOLD data. Newly-diagnosed and recurrent glioblastoma showed significantly lower (P 0.001) mCOV values compared to both normal brain and macrovasculature (MCOV) of the lesions. Recurrent glioblastoma had significantly higher mVTH (P ¼ 0.014) and mCOV (P ¼ 0.039) as well as significantly lower PO2 mit values (P ¼ 0.008) compared to newly-diagnosed glioblastoma. The macrovasculature, however, showed no significant differences. Our findings provide evidence of microvascular adaption in the disorganized tumor vasculature for retaining the metabolic demands in stress response of therapeutically-uncontrolled glioblastomas. Thus, mVTH and PO2 mit mapping gives insight into the tumor microenvironment (vascular and hypoxic niches) responsible for therapy resistance.
Introduction
Glioblastoma is the most common and aggressive primary brain tumor in adults with a median survival of only 14 months despite the best available treatments. 1 It is among the most vascularized of all solid tumors and characterized by its resistance to therapies. 2 Glioma-associated neovascularization is highly defective, resulting in a disorganized, abundant and aberrant vasculature with tortuous vessels of variable diameter and heterogeneous distribution, 3 abnormal capillary bed topology, arteriovenous shunting, microthromboses, etc. 4 This causes heterogeneity in blood flow and perfusion through the tumor vasculature and consequently impairs the delivery of nutrients, oxygen as well as therapeutics to tumor tissue.
Jespersen and Østergaard 7 extended the classic flowdiffusion equation to theoretically describe the effects of capillary flow patterns on brain oxygenation introducing capillary transit time heterogeneity (CTH) as an index to account for the distribution of microvascular flow patterns. 7 A review of the putative effects of elevated CTH as a result of changes in capillary morphology in tumors suggested that elevated CTH may reduce tissue oxygen availability. 8 Recently, it became possible to estimate vascular transit time heterogeneity (VTH) in terms of the CTH index based on dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI) data using the extended model equation. 9, 10 This approach has proved robust across realistic signalto-noise ratios [9] [10] [11] and demonstrated usefulness in patients with glioma, 10, 12, 13 acute stroke, 9 and bilateral high-grade internal carotid artery stenosis. 14 These studies, however, used a gradient-echo (GE) echo-planar imaging (EPI) DSC-MRI perfusion sequence. The GE-EPI DSC-MRI technique is the method of choice for routine clinical applications of DSC because of its relatively high contrast-to-noise ratio. It is well-known, however, that GE-EPI is equally sensitive to a broad range of (macro)vessel diameters (starting from 20 mm), 15 with reduced sensitivity to the microvascular range. 16 In contrast, despite its lower overall sensitivity to contrast agent-induced signal variations, spin-echo EPI (SE-EPI) DSC-MRI exhibits a peak sensitivity to the microvasculature at a vessel diameter around 10 mm, 15 including arterioles, capillaries, and venules. These differences in sensitivity to the vascular properties were shown in simulations studies 15, 17 and verified in practice. 18 Hypoxia is of crucial importance in tumor biology and therefore has the potential as a key imaging biomarker for illumination of pathophysiological mechanisms including therapy resistance and recurrence. Most of the available techniques, however, are not well suited for in vivo characterization of hypoxia in humans due to their invasiveness (electrodes), limited availability (PET), or low spatial resolution (NIR spectroscopy). An MRI-based multiparametric quantitative blood oxygenation level dependent (qBOLD) approach was recently proposed to obtain quantitative oxygenation information, namely oxygen extraction fraction and metabolic rate of oxygen. 19 MR-based assessment of tissue oxygen tension, however, was not assessable in humans so far.
The aim of this study was to introduce two MRI methods for assessment of physiological parameters: (i) mapping of transit time heterogeneity in the microvasculature with SE-EPI DSC-MRI data (termed ''VTH mapping'') and (ii) mapping of the oxygen tension in tissue surrounding mitochondria (PO2 mit ). These MRI techniques were used to investigate whether there are differences between macro-and microvascular transit time heterogeneity (MVTH and mVTH) and oxygen tension in newly-diagnosed and recurrent glioblastoma.
Materials and methods

Patients
The institutional review boards of the University of Erlangen (263_15 Bc) and the University Clinic of St. Po¨lten (GS1-EK-4/339-2015) approved this retrospective study. All patients gave written informed consent in accordance with the ethical standards of the Helsinki Declaration of 1975 and its later amendments. Written consent was obtained from all enrolled patients. Using an institutional database, we retrospectively identified patients with newly-diagnosed (untreated) or recurrent glioblastoma (World Health Organization [WHO] grade IV) who were diagnosed between July 2015 and September 2016. Inclusion criteria for our study were as follows: (i) aged !18 years; (ii) MR scans using our study MRI protocol available; (iii) pathologically confirmed glioblastoma based on the WHO histological grading system. Additional criteria for patients with recurrent glioblastoma only were as follows: (iv) patients were previously treated according to standard of care, which included maximal safe resection, radiotherapy, and concomitant and adjuvant chemotherapy with temozolomide; 20 (v) patients who received bevacizumab or alternative chemotherapy regimens as part of their initial treatment regimen (i.e., before tumor recurrence) were excluded; and (vi) recurrence was determined by at least two board-certified radiologists in consensus based on the updated Response Assessment in Neuro-Oncology (RANO) criteria 21 with clear radiological features of recurrence. For the VTH mapping experiments, we used (vi) a SE-EPI DSC perfusion sequence (TR, 1740 ms; TE, 33 ms; TA, 2 min) and a GE-EPI DSC perfusion sequence (TR, 1740 ms; TE, 22 ms; TA, 2 min), respectively, in combination with a dual contrast agent injections approach. 22, 23 Both DSC perfusion examinations were performed with 60 dynamic measurements and administration of 0.1 mmol/kg-bodyweight gadoterate-meglumine (Dotarem, Guerbet, Aulnay-sousBois, France) at a rate of 4 ml/s using a MR-compatible injector (Medrad Spectris, Bayer, Leverkusen, Germany). A 20-ml-bolus of saline was injected subsequently at the same rate. Geometric parameters were chosen identical for the four qBOLD and CTH sequences: in-plane resolution: 1.8 Â 1.8 mm, slice thickness: 4 mm; 29 slices; GRAPPA factor of 2.
MR image acquisition
MR image data processing
Post-processing of SE-EPI and GE-EPI DSC-MRI data was performed using the Perfusion Graphical User Interface (PGUI, http://www.cfin.au.dk/software/pgui) developed in Matlab (Mathworks, Natick, MA, USA), which implements DSC-MRI data analysis for VTH estimation using the extended flow-diffusion equation as described previously. 7 In short, the probability density function of vascular transit times h(t) is modeled by a gamma variate distribution with parameters a and b, according to
Àt= where R(t) ¼ 1ÀH(t) is the residue function and H(t) is the distribution function of the standard microvascular model. 11, 24 The contrast agent mean transit time (MTT) of a gamma variate is given by MTT ¼ Á , while VTH can be quantified by the standard deviation of the gamma variate, VTH ¼ Áˇ.
25
Since we obtained two sets of parameters (for SE-EPI and GE-EPI DSC-MRI data), we adopted their nomenclature: (i) for GE-EPI DSC-MRI data which were equally sensitive to a broad range of (macro) vessel diameters we used MVTH and MMTT, and (ii) for SE-EPI DSC-MRI data which had a peak sensitivity to the microvasculature (including arterioles, capillaries, and venules), we used mVTH and mMTT, respectively.
In a next step, color-coded maps of MVTH, MMTT, mVTH, and mMTT were calculated. Because of the inherent properties of vascular networks 26 VTH and MTT as well as mVTH and mMTT values are linearly correlated in normal brain tissue, but in glioma, prior studies have shown that this relationship is disturbed and calculated the coefficient of variation (MCOV and mCOV) as the MVTH/MMTT and mVTH/mMTT ratio, respectively.
12,13 Therefore, we additionally generated MCOV and mCOV maps in order to visualize the disturbed MVTH-MMTT and mVTH-mMTT correlations within the tumors.
Post-processing of qBOLD data was performed using custom-made Matlab software and consisted of three steps: (i) Corrections for background fields of the R 2 *-mapping data 27 and for stimulated echos of the R 2 -mapping data. 28 (ii) Calculation of R 2 *-and R 2 -maps from the multi-echo relaxometry data, and of absolute cerebral blood volume (CBV) and flow (CBF) maps from the GE-EPI DSC perfusion MRI data via automatic identification of arterial input functions (AIFs) from the signal of voxels containing a large artery. 29, 30 (iii) Calculation of maps for oxygen extraction fraction (OEF), cerebral metabolic rate of oxygen (CMRO 2 ), 19 and the average mitochondrial oxygen tension (PO2 mit ) 31, 32 using the following equations
is the difference between the magnetic susceptibilities of fully oxygenated and fully deoxygenated haemoglobin; Hct ¼ 0.42Á0.85 is the microvascular hematocrit fraction)
where C a ¼ 8.68 mmol/ml is the arterial blood oxygen content
where P 50 is the hemoglobin half-saturation tension of oxygen (27 mmHg) 
Results
In total, 57 patients with newly-diagnosed (untreated) or recurrent glioblastoma were included in this study based on our criteria. Twenty-five patients (10 women, 15 men; mean age AE standard deviation, 64.8 AE 11.9 years) suffered from a newly-diagnosed glioblastoma, and 32 patients (16 women, 16 men; 63.3 AE 9.7 years) from a recurrent glioblastoma, respectively. All patients with recurrent glioblastoma received the Stupp protocol. 20 Nine patients, however, received less than six cycles temozolomide (3-5 cycles) due to side effects. Representative cases for VTH mapping of the macroand microvasculature in patients with newly-diagnosed and recurrent glioblastoma are depicted in Figure 1 (a) and (b), respectively. The findings for the 25 patients with newly-diagnosed glioblastoma and the 32 patients with recurrent glioblastoma are summarized in Table 1 .
Differences in VTH mapping between glioblastoma and normal brain
As expected and described previously, VTH mapping parameters derived from GE-EPI DSC-MRI data (i.e. for macrovasculature; MVTH, MMTT, and MCOV) of glioblastoma were increased compared to normal brain (second column in Figure 1) . However, only for recurrent glioblastoma were these differences to normal brain significant (all P < 0.05), except for MMTT, which was not significantly different to iNAB. The differences between newly-diagnosed glioblastoma and normal brain for the VTH mapping parameters in the macrovasculature did not reach significance (upper part of Table 1 ).
On the other hand, mVTH and mMTT for the microvasculature of both newly-diagnosed and recurrent glioblastoma were significantly increased (for all P 0.001) compared to normal brain. Nevertheless, mCOV values, i.e. the mVTH/mMTT ratios, were significantly decreased (for all P 0.001) in both newly-diagnosed and recurrent glioblastoma compared to normal brain (middle part of Table 1) .
In other words, the relative vascular transit time heterogeneity was increased in the macrovasculature (MCOV) but decreased in the microvasculature (mCOV) of glioblastoma compared to normal brain (third column in Figure 1 ).
Differences in VTH mapping between macro-and microvasculature
In microvasculature, mVTH and mMTT were significantly larger (P ¼ 0.011 to <0.001) compared to their equivalents in macrovasculature (MVTH and MMTT) for all ROIs in patients with both newly-diagnosed and recurrent glioblastoma.
The value for mCOV in normal brain (iNAB and cNAB) and edema were also significantly larger (P ¼ 0.024 to 0.001) compared to macrovasculature (MCOV). Within newly-diagnosed and recurrent glioblastoma, however, mCOV was significantly lower (both P < 0.001) compared to MCOV. In other words, in glioblastoma, the relative transit time heterogeneity in the microvasculature was significantly lower than in the macrovasculature (compare second and third column in Figure 1 , or third and sixth row in Table 1 ).
Differences between newly-diagnosed and recurrent glioblastoma
Recurrent glioblastoma showed significantly increased mVTH (P ¼ 0.014; Figure 2(a) ) and mCOV values (P ¼ 0.039; Figure 2 (c)) compared to newly-diagnosed glioblastoma. For mMTT, we also found higher values in recurrent glioblastoma which, however, did not reach significance (P ¼ 0.162; Figure 2(b) ). This was associated with significantly decreased (P ¼ 0.008) PO2 mit values in recurrent glioblastoma (Figure 2(d) ). For VTH mapping in the macrovasculature (MVTH, MMTT, MCOV), we found no significant differences between newly-diagnosed and recurrent glioblastoma.
Correlations between transit time heterogeneities and MTTs
The correlations of MVTH vs. MMTT and mVTH vs. mMTT for the subgroups of patients with newly-diagnosed and recurrent glioblastoma are depicted in the first and second plots of Figure 3 (a) and (b), respectively. The MVTH vs. MMTT correlation demonstrated a superposition for normal brain (iNAB and cNAB), edema, and tumor (first column in Figure 3) . Interestingly, the mVTH vs. mMTT scatterplots showed a separation between normal brain/edema and tumor (second column in Figure 3 ). The third plots in Figure 3 (a) and (b)give an overview for the differences in correlations between macro-and microvasculature in newly-diagnosed and recurrent glioblastoma, respectively.
Regression analyses between MVTH vs. MMTT and mVTH vs. mMTT generally revealed better correlations for the more complex model (quadratic polynomial with three parameters) compared to the more restricted Figure 1 . VTH mapping of the macro-and microvasculature and PO2 mit mapping in (a) a 46-year-old male patients suffering from a newly-diagnosed glioblastoma and (b) a 63-year-old female patients suffering from a recurrent glioblastoma. First column, contrastenhanced T1-weighted (CE T1w) MR images and FLAIR MR images. Second column, results for VTH mapping using GE-EPI DSC-MRI data in order to obtain maps of macrovascular VTH (MVTH) and coefficient of variation (MCOV). Third column, results for VTH mapping using SE-EPI DSC-MRI data in order to obtain maps of microvascular VTH (mVTH) and coefficient of variation (mCOV). Last column, maps of absolute cerebral blood volume (CBV) obtained from GE-EPI DSC-MRI data and oxygen tension in tissue surrounding mitochondria (PO2 mit ).
model (linear with two parameters), which was mathematically coherent. In normal appearing brain tissue (iNAB and cNAB), however, the differences in correlation coefficients between the two models were very minor (in the third digital place) and not statistically significant using an F-test. Therefore, the assumption of a linear correlation in NAB was justified. The linear correlation coefficients in NAB were as follows: MVTH vs. MMTT, R 2 ¼ 0.918 (newly-diagnosed glioblastoma) and R 2 ¼ 0.904 (recurrent glioblastoma); mVTH vs. mMTT; R 2 ¼ 0.902 (newly-diagnosed) and R 2 ¼ 0.686 (recurrent). The correlation coefficients in peritumoral edema were very similar.
The microvasculature (mVTH vs. mMTT) of recurrent glioblastoma showed a significantly stronger correlation (P ¼ 0.038) for quadratic polynomial regression model (R 2 ¼ 0.922) compared to the linear model (R 2 ¼ 0.854). However, the differences in correlations for the microvasculature of newly-diagnosed glioblastoma and the macrovasculature (MVTH vs. MMTT) of both glioblastoma subtypes were not significant. The quadratic polynomial correlation coefficients were as follows: mVTH vs. mMTT in newlydiagnosed glioblastoma, R 2 ¼ 0.848; MVTH vs. MMTT, R 2 ¼ 0.890 (newly-diagnosed) and R 2 ¼ 0.875 (recurrent, see third plots in Figure 3 
Discussion
This study introduces a physiological MRI approach including micro-and macrovascular VTH and PO2 mit mapping. This enabled us to demonstrate that pathologic VTH alterations in glioblastoma are dominated by microvasculature (vessel diameters around 10 mm) and revealed three main findings regarding the pathophysiology of glioblastoma: (i) the relative VTH was decreased in microvasculature (mCOV) but increased in macrovasculature (MCOV) compared to the other brain regions (iNAB, cNAB, and edema); (ii) recurrence of glioblastoma was associated with elevated microvascular perfusion dispersion (mVTH, mCOV) and (iii) increased hypoxia (decreased PO2 mit ) compared to newly-diagnosed glioblastoma.
Firstly, the finding of decreased mCOV values in glioblastoma was remarkable and unexpected. With mCOV values <1.0 in both newly-diagnosed and recurrent glioblastoma and mCOV ! 1.3 in other brain regions, the differences were distinct and significant. MCOV values, however, were increased within the lesions. To the best of our knowledge, the investigation of VTH using the SE-DSC perfusion MRI technique, which is more sensitive to the microvasculature, in patients with glioblastoma has been not described so far. Our findings regarding increased mVTH and mMTT, however, are in line with the theoretical considerations of a review about the putative effects of changes in capillary morphology in tumors. 8 Although both mVTH and mMTT are markedly increased compared to normal brain, the low mCOV (i.e. mVTH/mMTT ratio) values indicate a decrease in mVTH (standard deviation of transit time distribution) relative to mMTT (mean value of transit time distribution). This may provide evidence for a mechanism of adaption of microvasculature to retain the high metabolic demands of the lesion within a disorganized and inefficient vasculature. Our findings for the transit time heterogeneity in the macrovasculature of glioblastoma are in accordance with previous studies using the standard GE-DSC perfusion MRI technique which have shown that the relationship between MMTT and MVTH is altered, resulting in elevation of the MCOV values. 12, 13 The differences in micro-and macrovascular VTH mapping were supported by our regression analyses, which confirmed, on the one hand, the common assumption 13 of a linear correlation between VTH and MTT in the normal micro-and macrovascular bed. On the other hand, we revealed significant differences for the correlations between micro-and macrovasculature in glioblastoma. This may be interpreted as a further evidence for decoupling of mVTH and mMTT in glioblastomas.
Secondly, we revealed that recurrent glioblastoma showed significantly increased perfusion dispersion in the microvasculature (mVTH, mCOV) compared to newly-diagnosed glioblastoma. This is an indication for stress response of the microvascular network in failed-therapy glioblastoma in order to protect tumor cells by an intact neurovascular unit, 35 which was already suggested by the observations of previous studies. 12, 36 A close association between endothelial cells and neural stem cells was demonstrated in a seminal work of Shen et al. 37 They found that endothelial cells secrete factors that stimulate self-renewal of neural stem cells and proposed that endothelial cells are an integral component of the stem cell niche. This vascular niche has also been applied to glioblastoma stem cells. 38, 39 It can be thought of as protective microenvironment in which glioblastoma stem cells are able to freely proliferate and remain undifferentiated, completely unaffected by any external influences. 38, 39 Moreover, a combined effect of high VTH and blood flow was predicted to be associated with insufficient oxygen extraction and hypoxia. 7 This was supported with patient data demonstrating an increased expression of hypoxia markers in tissue regions with altered capillary transit times. 40 Finally, our finding of significantly decreased PO2 mit in failed-therapy glioblastoma compared to both normal brain tissue and newly-diagnosed glioblastoma is in accordance with the well-known role of hypoxia in therapy resistance of glioblastoma. Tumor progression and resistance to both radiotherapy and chemotherapy are associated with a hypoxic tumor microenvironment known as hypoxic niche. 1, 41, 42 Hypoxia promotes a more malignant phenotype of cancer cells and supports the survival of glioma stem cells which possess greater drug resistance, self-renewal potential and tumorigenicity. [43] [44] [45] Our data support the assumption for an association between the vascular and the hypoxic niche. Tumor-initiating stem cells thrive in hypoxic environments which are localized in peri-capillary niches where the aberrant capillary networks appear to offer optimal conditions for tumor maintenance, as well as therapy resistance. 38, 39 This study has several limitations. There is no clear benefit for the routine clinical management of patients of the demonstrated differences in vascular heterogeneity and PO2 mit between newly-diagnosed and recurrent glioblastoma. However, our approach may be helpful for therapy monitoring or to develop new therapeutic strategies for glioblastoma. Furthermore, biological validation of the MR-based parameters for vascular transit time heterogeneity and tissue oxygen tension is required by correlation with findings from immunohistochemistry of biopsies, results from examinations using invasive methods, 46, 47 or data from other imaging modalities (e.g. positron emission tomography). 48 Thereby, the link between the mathematical models of our approach and biology could be understood in more detail. The PO2 mit values in newly-diagnosed and recurrent glioblastoma are quite high compared to data from studies using invasive methods. 49 A reason for this might be the fact that PO2 mit in our study is a derived parameter based on MR experiments with a lower spatial resolution compared to invasive, more direct methods. 49 The SE-DSC perfusion sequence has lower contrast to noise compared to the GE-DSC approach. This is related to the generally lower sensitivity to magnetic susceptibility of SE MRI sequences compared to the highly susceptibility-sensitive GE sequences. However, this different sensitivity to magnetic susceptibility is the crucial reason for their vessel-size-dependence. Additionally, the injection of a double dose of contrast agent with two separate injections is required. A combined GE-SE perfusion sequence with the Simultaneous-MultiSlice (SMS) technique may help to overcome this limitation. 50 Finally, our PO2 mit mapping approach needs validation with invasive methods in animal models.
In conclusion, mVTH and PO2 mit mapping provides potential imaging biomarkers for investigation of physiological and metabolic alterations in glioblastoma including the vascular and hypoxic niche, which are responsible for tumor progression and therapy resistance of glioblastoma. However, further studies including patients with anaplastic and low-grade glioma, pseudo-progression, and under anti-angiogenetic or more advanced therapies are required. 
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